Abstract
In selecting and defining composite end points in clinical trials, are we trading off clinical significance for statistical significance?
MeSH terms
-
Angioplasty, Balloon, Coronary / methods
-
Clinical Trials as Topic / standards*
-
Coronary Artery Bypass / methods
-
Hemorrhage / etiology
-
Humans
-
Myocardial Infarction / diagnosis
-
Myocardial Infarction / therapy*
-
Safety Management
-
Treatment Outcome